The global Continuous Renal Replacement Therapy (CRRT) Market size was valued at around USD 745.4 million in 2016 and is anticipated to reach USD 1.4 billion by 2025, with a CAGR of 7.4%. Acute renal failure is a common complication in the intensive care unit (ICU). Over the last few years, there have been noteworthy technological developments in the delivery of renal replacement therapy, principally as it refers to the critically ill patient population.
Continuous Renal Replacement Therapy (CRRT) is a dialysis modality utilized to treat critically ill, hospitalized patients in the intensive care unit (ICU) who develop acute kidney injury (AKI). Dissimilar to that of chronic kidney disease, which arises gradually over the period of time, AKI often takes place in hospitalized patients treated in an intensive care environment, and it classically occurs over a few hours to a few days.
Renal replacement therapy is one treatment modality that strives for the replacement of the excretory function of the kidney. Renal replacement always utilizes a semi-permeable membrane to accomplish blood purification. It can be alternating or continuous, and can involve some of the major transport mechanisms such as the convection, adsorption, diffusion, and ultra-filtration. The effort of this is continuous renal replacement rehabilitation.
Continuous renal replacement therapy (CRRT) is a widespread optimal for the cure of ICU patients with AKI, particularly for hemodynamically unbalanced circumstances. CRRT consists of solute removal from blood by hemofiltration or haemodialysis or a blend of both. CRRT is carried out for about 24 hours in an ICU, making it relatively different from traditional renal replacement therapies that consist of intermittent haemodialysis durable from four to six hours or even at a reduced rate. Therefore, CRRT was established in an effort to offer artificial kidney support to those patients who could not abide the traditional haemodialysis as traditional intermittent haemodialysis often causes hemodynamic instability in the critically ill patients. The patients in receipt of CRRT can obtain as much as protein as well as fluid required achieving optimum nutrition.